Yanagihara K - Search Results

1

Expression of thymidylate synthase in human non-small cell lung cancer.

Otake Y, Tanaka F, Yanagihara K, Hitomi S, Okabe H, Fukushima M, Wada H. Otake Y, et al. Among authors: yanagihara k. Jpn J Cancer Res. 1999 Nov;90(11):1248-53. doi: 10.1111/j.1349-7006.1999.tb00704.x. Jpn J Cancer Res. 1999. PMID: 10622537 Free PMC article.

2

Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.

Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Inui K, Oyanagi H, Yamada T, Nakayama J, Fujimoto I, Ikenaka K, Wada H. Tanaka F, et al. Among authors: yanagihara k. Cancer Res. 2001 Feb 15;61(4):1666-70. Cancer Res. 2001. PMID: 11245481

3

Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC).

Tanaka F, Yanagihara K, Otake Y, Yamada T, Shoji T, Miyahara R, Inui K, Wada H. Tanaka F, et al. Among authors: yanagihara k. Eur J Cardiothorac Surg. 2001 May;19(5):555-61. doi: 10.1016/s1010-7940(01)00670-4. Eur J Cardiothorac Surg. 2001. PMID: 11343930

4

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H. Tanaka F, et al. Among authors: yanagihara k. Clin Cancer Res. 2001 Nov;7(11):3410-5. Clin Cancer Res. 2001. PMID: 11705856

5

Clinical significance of caspase-3 expression in pathologic-stage I, nonsmall-cell lung cancer.

Takata T, Tanaka F, Yamada T, Yanagihara K, Otake Y, Kawano Y, Nakagawa T, Miyahara R, Oyanagi H, Inui K, Wada H. Takata T, et al. Among authors: yanagihara k. Int J Cancer. 2001;96 Suppl:54-60. doi: 10.1002/ijc.10347. Int J Cancer. 2001. PMID: 11992386

6

Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients.

Ogawa E, Takenaka K, Yanagihara K, Kurozumi M, Manabe T, Wada H, Tanaka F. Ogawa E, et al. Among authors: yanagihara k. Br J Cancer. 2004 Aug 2;91(3):498-503. doi: 10.1038/sj.bjc.6601992. Br J Cancer. 2004. PMID: 15226767 Free PMC article.

7

Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer.

Fukuse T, Hirata T, Tanaka F, Yanagihara K, Hitomi S, Wada H. Fukuse T, et al. Among authors: yanagihara k. Eur J Cardiothorac Surg. 1997 Aug;12(2):218-23. doi: 10.1016/s1010-7940(97)00122-x. Eur J Cardiothorac Surg. 1997. PMID: 9288510 Clinical Trial.

8

Time trends and survival after surgery for p-stage IIIa, pN2 non-small cell lung cancer (NSCLC).

Tanaka F, Yanagihara K, Ohtake Y, Fukuse T, Hitomi S, Wada H. Tanaka F, et al. Among authors: yanagihara k. Eur J Cardiothorac Surg. 1997 Sep;12(3):372-9. doi: 10.1016/s1010-7940(97)00204-2. Eur J Cardiothorac Surg. 1997. PMID: 9332914

9

Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).

Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H. Tanaka F, et al. Among authors: yanagihara k. Eur J Cardiothorac Surg. 1998 Sep;14(3):256-62; discussion 263-4. doi: 10.1016/s1010-7940(98)00186-9. Eur J Cardiothorac Surg. 1998. PMID: 9761434

10

Lewis Y antigen expression and postoperative survival in non-small cell lung cancer.

Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H. Tanaka F, et al. Among authors: yanagihara k. Ann Thorac Surg. 1998 Nov;66(5):1745-50. doi: 10.1016/s0003-4975(98)00937-0. Ann Thorac Surg. 1998. PMID: 9875782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,135 results

Search Page

Filters